FIGURE 3.
Cumulative incidence within 18 months of listing for waitlist mortality. Cumulative incidence within 18 months of listing during Era 1 for (A) ALD, (B) HCC, and (C) other and Era 2 for (D) ALD, (E) HCC, and (F) Other is shown in Figure 2. Waitlist mortality was significantly higher among those with HCC (E) and other (F) in Era 2 in the highest ATxV tertile (T3). Abbreviations: ALD, alcohol-associated liver disease; ATxV, transplant volume for alcohol-associated liver disease.
